According to the company, the AccuVax Vaccine Management System streamlines vaccine workflow, saves nursing time, minimizes vaccine waste, safeguards vaccine potency, and helps protect against medical errors.
Vaccines are one of the most significant public health successes. Yet, lapses in handling can render a vaccine ineffective and may leave people unprotected or needing revaccination, according to the Centers for Disease Control and Prevention.
Inventory losses due to power failure, improper storage and expired doses are common, and have created challenges for even the most advanced practices and health systems.
According to the company, AccuVax offers key advantages over conventional vaccine refrigeration and storage practices.
The system automates time-consuming storage, handling, and documentation tasks. It also dramatically simplifies compliance with CDC guidelines, as well as the requirements of the federally funded vaccine program.
AccuVax is the purpose-built vaccine supply management system that automates product control and integrity, minimises risks of incorrect vaccine delivery, and optimises office work flow so that providers can focus on care delivery.
It is an integrated solution that includes hardware, software, online access, software updates, training, optional integrations, technical support and maintenance.
TruMed Systems, a medical technology company developing innovative point-of-care supply management systems for healthcare professionals.
FDA grants priority review for GSK's gepotidacin gonorrhoea indication
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
FDA lifts pause on Valneva's chikungunya vaccine IXCHIQ for elderly, updates prescribing information
Anixa Biosciences begins US FDA approved IND transfer to support Phase 2 breast cancer vaccine trial
Pfizer and BioNTech receive EU regulatory backing for LP.8.1-adapted COVID-19 vaccine
Sanofi to acquire Vicebio for USD1.15bn to strengthen respiratory vaccine pipeline
Bavarian Nordic chikungunya vaccine enters Health Canada review process
SK bioscience submits IND for Phase 1/2 clinical trial of new influenza vaccine candidate
GC Biopharma secures Vietnamese approval for varicella vaccine BARYCELA
GSK announces submission of RSV vaccine Arexvy for FDA review
PharmaJet signs MOU with Egyptian UPA and EVA Pharma to introduce needle-free vaccine delivery
Centivax raises USD45m to commercialise universal flu vaccine
CyanVac's nasal COVID vaccine shows promise in phase 1 trial
hVIVO supports Cidara Therapeutics' positive Phase 2b influenza study results